Biotech
> NuCana appointed Chris McGuigan as chief scientific officer. Release
> Inocrin named Charles Osborne Jr. as chief financial officer. Release
> Voyager Therapeutics added Perry Karsen to its board of directors. Release
> Sarepta ($SRPT) appointed Henri Termeer as advisor to the company. Release
> Merganser Biotech appointed Remy Sukhija as chief operating officer. Release
> Mission Therapeutics added Colin Goddard to its board of directors. Release
> Joseph Krivulka and Martin Simonetti joined Prismic Pharmaceuticals' board of directors. Release
> CAS Medical Systems ($CASM) elected Alan Milinazzo to its board of directors. Release
> Insulet ($PODD) promoted Mark Licari to VP of global manufacturing and operations and recruited David Colleran as VP and general counsel. COO Patrick Ryan has resigned. Release
> Collegium ($COLL) hired John "Jack" Weet as VP of regulatory affairs and quality assurance. Release
> William Haskel joined Paratek Pharma as senior vice president, general counsel and corporate secretary. Release
> Bellerophon Therapeutics ($BLPH) appointed Amit Agrawal as chief operating officer and Dr. Naseem Amin as independent director of the company. Release
> Innocoll ($INNL) named Jose Carmona as chief financial officer. Release
> Strand Life Sciences appointed Scott Storrer as CEO. Release
> Flamel Technologies ($FLML) appointed Sandy Hatten as its senior vice president of quality and regulatory affairs and Gregory Davis as its vice president of business and corporate development. Release
> Torsten Hoffmann joined Proteros Biostructures as its chief scientific officer. Release
> vTv brought on Rudy Howard as its chief financial officer. Release
> Marathon Pharmaceuticals named Joe Nolan its chief commercial officer. Release
> Yixin Wang joined DeNovo Sciences as the company's chief scientific officer. Release
> Catalyst Pharmaceuticals ($CPRX) appointed Dr. Gary Ingenito as its chief medical officer. Release
> Genisphere appointed Thomas Bliss as its new CEO. Release
Vaccines
> Vaccibody appointed Martin Bonde as its CEO. Release
|